TABLE 2.
Protein | Substrate degradationb phenotype (during coexpression with E4orf6 alone) for:
|
Substrate degradationc phenotype (during virus infection) for:
|
Substrate bindingd phenotype for:
|
Aggregate colocalizatione phenotype for:
|
Cytoaggregatef phenotype | Nuclear retention by E4orf6g | Concatemer formationh phenotype | Additional reference(s)j | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
p53 | MRN | Lig4 | p53 | MRN | Lig4 | p53 | MRN | p53 | MRN | |||||
WT E1b55K | + | + | + | + | + | + | + | + | + | + | + | + | − | |
L83,87,89A (NES mutant protein) | ND | + | ND | ± | + | ND | + | + | + | + | NA | + | ND | 20, 31, 36, 39 |
K104R | ND | + | ND | + | + | ND | ND | + | ND | + | + | + | ND | 21, 36 |
H224 insertion mutant protein | + | + | + | + | + | + | + | + | + | ± | + | ± | − | 26, 34, 52, 72 |
R240A | − | + | + | − | + | + | − | + | − | ± | + | + | − | 12, 56 |
C348,351S | ND | + | ND | ND | ND | ND | ND | ND | ND | ND | + | + | ND | |
H354 insertion mutant protein | + | − | + | + | − | + | + | − | + | − | + | + | − | 12, 26, 34, 42, 52, 71, 72 |
C361,366S | − | − | − | − | − | − | ± | − | + | − | + | ± | + | |
H373A | + | − | + | + | − | + | + | − | + | − | + | + | − | |
R443 insertion mutant protein | ± | − | + | ± | − | ± | + | − | + | − | +/diffuse | ± | + | 26, 34, 52, 58, 71, 72 |
Y444A | + | + | + | + | ± | + | + | ± | + | ± | + | ± | − | 56 |
C454,456S | − | − | − | − | − | − | + | − | + | −i | + | ± | + | 31 |
S490,491,T495A (3XPA) | − | + | ± | − | − | − | − | − | NA | NA | Diffuse | ± | + | 50, 62 |
S490,491,T495D (3XPD) | ± | + | + | ND | ND | ND | + | + | + | ± | + | + | − |
Unless otherwise indicated, symbols and abbreviations are as follows: +, proficient (may not reflect WT E1b55K activity); ±, defective; −, very defective; ND, not determined; NA, not applicable.
Degradation of endogenous proteins by E1b55K mutant forms in the presence of rAdE4orf6 as assessed by Western blotting or immunofluorescence analysis.
Degradation of endogenous proteins assessed in the context of viruses expressing E1b55K mutant proteins or E1b55K mutant cell lines infected with dl3112.
Interaction measured by coimmunoprecipitation experiments.
MRN or p53 colocalization with E1b55K aggregates as assessed by immunofluorescence.
E1b55K staining in the absence of rAdE4orf6 was assayed by using immunofluorescence. +, presence of E1b55K aggregates; diffuse, diffuse cytoplasmic E1b55K. See Fig. 4A and the corresponding legend for data and details.
E1b55K staining in the presence of rAdE4orf6 was assayed by using immunofluorescence. See Fig. 4A and the corresponding legend for data and details.
Concatemer formation by mutant virus dl3112 measured in mutant E1b55K-expressing cells.
Observation from the present study based on E1b55K expression in human cells.
This table summarizes data from this paper as well as the additional references indicated.